Rice University scientists have found a way to predict rapidly whether a new strain of the influenza virus should be included in the annual seasonal flu vaccine. While it sometimes takes new flu strains up to three years ...
Nov 15, 2010
not rated yet
0
A Phase I study, called RV262, recently began to evaluate a combination DNA prime/MVA vector boost vaccine regimen that was developed to protect against diverse subtypes of HIV-1 prevalent in North America, Europe, Africa ...
Sep 28, 2010
not rated yet
0
(PhysOrg.com) -- National Jewish Health has received a US patent for a new kind of vaccine, which uses a small lipid bubble to deliver an antigen and DNA adjuvant.
Sep 27, 2010
not rated yet
0
(PhysOrg.com) -- Scientists have developed the first cell controlled by a synthetic genome. They now hope to use this method to probe the basic machinery of life and to engineer bacteria specially designed ...
May 20, 2010
4.8 / 5 (37)
79
|
Laboratory research and clinical studies are beginning to demonstrate that DNA vaccines can be as effective as traditional vaccines, reports Genetic Engineering & Biotechnology News (GEN). A number of factors are driving ...
Apr 19, 2010
not rated yet
0
(PhysOrg.com) -- An analysis of vaccines undertaken by researchers from 5 institutions has found that 7 of the vaccines' DNA content was pretty much as expected, but surprisingly, one also contained DNA of ...
Apr 09, 2010
4 / 5 (1)
1
|
(PhysOrg.com) -- A global collaborative has produced a first draft of the genome of a domesticated pig, an achievement that will lead to insights in agriculture, medicine, conservation and evolution.
Nov 02, 2009
5 / 5 (1)
0
Supporting Los Alamos National Laboratory's role in the international Center for HIV/AIDS Vaccine Immunology (CHAVI) consortium, researchers are using the Roadrunner supercomputer to analyze vast quantities of genetic sequences ...
Oct 27, 2009
3 / 5 (1)
0
